Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MM-RCTIndependent statistical analysis of Moving Mindfully for Freezing of Gait: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05923229).
- MMAIndependent statistical analysis of Men, Mood, and Attention Study: Examination of Alcohol, State Anger, and Emotion Regulation Sexual Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MMBIIndependent statistical analysis of Improving Balance and Mobility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02374463).
- MMF for HIV Reservoir Reduction: Complete Statistical AnalysisIndependent statistical analysis of MMF for HIV Reservoir Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262441).
- MMFPRIMERIndependent statistical analysis of Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01282073).
- MMNEIndependent statistical analysis of Effect of Medical Marijuana on Neurocognition and Escalation of Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03224468).
- MMPIndependent statistical analysis of Methadone Maintenance for Prisoners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00378079).
- MMPHIndependent statistical analysis of Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MMPOWERIndependent statistical analysis of Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MMRIndependent statistical analysis of A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- mMRPIndependent statistical analysis of Pilot Trial of Mobile Mantram Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05998967).
- MMVAR – Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation: Complete Statistical AnalysisIndependent statistical analysis of MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MN4000 for Treatment of CF and MND Patients in the Home Setting: Complete Statistical AnalysisIndependent statistical analysis of MN4000 for Treatment of CF and MND Patients in the Home Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: Complete Statistical AnalysisIndependent statistical analysis of MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00794508).
- MNSIndependent statistical analysis of Median Nerve Stimulation Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04731714).
- MOBEIndependent statistical analysis of Motivated Behavior in Adults With and Without ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02630017).
- MOBILEIndependent statistical analysis of MOBILE Intervention in College Students With Elevated Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05956925).
- Mobile – Bearing Knee Study: Complete Statistical AnalysisIndependent statistical analysis of Mobile - Bearing Knee Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00765362).
- Mobile Attention Retraining in Overweight Female Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Mobile Attention Retraining in Overweight Female Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02977403).
- Mobile Communication Technology for Adolescents With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Mobile Communication Technology for Adolescents With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605839).
- Mobile Health and COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health and COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05074693).
- Mobile Health for Alcohol Use Disorders in Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health for Alcohol Use Disorders in Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04011644).
- Mobile Health Intervention for Active Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health Intervention for Active Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03544476).
- Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mobile WAChxIndependent statistical analysis of Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men: Complete Statistical AnalysisIndependent statistical analysis of Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MOBILITYIndependent statistical analysis of Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MOBILITY APIndependent statistical analysis of Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common…
- Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients: Complete Statistical AnalysisIndependent statistical analysis of Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mobilizing Evidence Into Action to Improve Outcomes of Vulnerable Seniors: Complete Statistical AnalysisIndependent statistical analysis of Mobilizing Evidence Into Action to Improve Outcomes of Vulnerable Seniors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01254942).
- Mobilizing Social Network Resources for HIV Care Support: Complete Statistical AnalysisIndependent statistical analysis of Mobilizing Social Network Resources for HIV Care Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05123274).
- Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mod-NalIndependent statistical analysis of Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142818).
- MODELIndependent statistical analysis of Lifestyle Modification and Liraglutide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911818).
- Model 20105 Lead Study: Complete Statistical AnalysisIndependent statistical analysis of Model 20105 Lead Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02301429).
- Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3: Complete Statistical AnalysisIndependent statistical analysis of Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Modeling Stress-precipitated Smoking Behavior for Medication Development: Complete Statistical AnalysisIndependent statistical analysis of Modeling Stress-precipitated Smoking Behavior for Medication Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00773357).
- Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone: Complete Statistical AnalysisIndependent statistical analysis of Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Moderate to Severe Plaque Psoriasis With Scalp Involvement: Complete Statistical AnalysisIndependent statistical analysis of Moderate to Severe Plaque Psoriasis With Scalp Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00791765).
- MODERNIndependent statistical analysis of Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: Complete Statistical AnalysisIndependent statistical analysis of Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02806869).
- Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV: Complete Statistical AnalysisIndependent statistical analysis of Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01405313).
- Modified Dakin’s Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas: primary endpoint results, effect estimate with…
- Modified Instrumentation for Surgery to Correct Trichiasis: Complete Statistical AnalysisIndependent statistical analysis of Modified Instrumentation for Surgery to Correct Trichiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00886015).
- Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062): Complete Statistical AnalysisIndependent statistical analysis of Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01463683).
- Modified Reporting From Indwelling Catheters: Complete Statistical AnalysisIndependent statistical analysis of Modified Reporting From Indwelling Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03488355).
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition: Complete Statistical AnalysisIndependent statistical analysis of Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…